Tumor cells fuse with immune cells and become more aggressive
September 12, 2018
The hybrid cells, readily detected in cancer patients’ blood, gain new powers to mobilize and form new tumors.
Stories
Knight Cancer Research Building opens new era in cancer research
September 07, 2018
State-of-the-art cancer research facility will support a collaborative atmosphere, bring multidisciplinary scientists together under one roof.
Research team discovers drug compound that stops cancer cells from spreading
June 22, 2018
Via a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.
OHSU PDX Skincare Festival aims to celebrate — and protect — your skin
May 14, 2018
Annual community event will offer free skin cancer exams, samples and services from skin care professionals, and a 5K Walk or Fun Run to benefit melanoma research.
Sneak peek: Inside the Knight Cancer Institute research building (photos)
March 29, 2018
OHSU’s 320,000 square foot cancer research building is taking shape, with completion slated for late summer 2018.
Newly approved drug is effective in patients with prostate cancer
March 27, 2018
Apalutamide significantly delayed the onset of symptoms, metastasis or death in Phase III clinical trial.
Cancer researcher finds exercise DVD significantly improves fatigue symptoms in patients with breast cancer
November 20, 2017
Patients say exercise video is helpful at all stages of diagnosis and recovery.
OHSU, CMH collaborate to bring radiation therapy to the north Oregon coast
September 28, 2017
Preparations are underway for the opening of the new CMH-OHSU Knight Cancer Collaborative in Astoria.
OHSU Knight Cancer Institute earns National Cancer Institute’s highest distinction
July 10, 2017
OHSU Knight Cancer Institute has been awarded the National Cancer Institute’s, NCI, premier status: Comprehensive Cancer Center.
Technology expert joins the OHSU Knight Cancer Institute’s center for cancer early detection
June 22, 2017
Today the OHSU Knight Cancer Institute announced that internationally renowned bioengineering and technology expert Mike Heller, Ph.D., will join the institute’s Cancer Early Detection Advanced Research Center, or CEDAR, to lead its technology efforts.
